Therapeutic Solutions International Stock Market Value

TSOI Stock  USD 0.0005  0.0001  16.67%   
Therapeutic Solutions' market value is the price at which a share of Therapeutic Solutions trades on a public exchange. It measures the collective expectations of Therapeutic Solutions International investors about its performance. Therapeutic Solutions is trading at 5.0E-4 as of the 30th of November 2024. This is a 16.67 percent decrease since the beginning of the trading day. The stock's open price was 6.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Therapeutic Solutions International and determine expected loss or profit from investing in Therapeutic Solutions over a given investment horizon. Check out Therapeutic Solutions Correlation, Therapeutic Solutions Volatility and Therapeutic Solutions Alpha and Beta module to complement your research on Therapeutic Solutions.
Symbol

Please note, there is a significant difference between Therapeutic Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Therapeutic Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Therapeutic Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Therapeutic Solutions 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Therapeutic Solutions' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Therapeutic Solutions.
0.00
10/31/2024
No Change 0.00  0.0 
In 31 days
11/30/2024
0.00
If you would invest  0.00  in Therapeutic Solutions on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Therapeutic Solutions International or generate 0.0% return on investment in Therapeutic Solutions over 30 days. Therapeutic Solutions is related to or competes with Ensysce Biosciences, Aptorum Group, Alpha Cognition, Biomx, Zura Bio, and ZyVersa Therapeutics. Therapeutic Solutions International, Inc More

Therapeutic Solutions Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Therapeutic Solutions' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Therapeutic Solutions International upside and downside potential and time the market with a certain degree of confidence.

Therapeutic Solutions Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Therapeutic Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Therapeutic Solutions' standard deviation. In reality, there are many statistical measures that can use Therapeutic Solutions historical prices to predict the future Therapeutic Solutions' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.000610.55
Details
Intrinsic
Valuation
LowRealHigh
0.000.000510.55
Details
Naive
Forecast
LowNextHigh
0.0000060.000310.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00040.00070
Details

Therapeutic Solutions Backtested Returns

Therapeutic Solutions owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0185, which indicates the firm had a -0.0185% return per unit of risk over the last 3 months. Therapeutic Solutions International exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Therapeutic Solutions' Risk Adjusted Performance of 0.0112, semi deviation of 7.83, and Coefficient Of Variation of 38934.79 to confirm the risk estimate we provide. The entity has a beta of -3.32, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Therapeutic Solutions are expected to decrease by larger amounts. On the other hand, during market turmoil, Therapeutic Solutions is expected to outperform it. At this point, Therapeutic Solutions has a negative expected return of -0.2%. Please make sure to validate Therapeutic Solutions' total risk alpha and the relationship between the potential upside and day typical price , to decide if Therapeutic Solutions performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.24  

Weak reverse predictability

Therapeutic Solutions International has weak reverse predictability. Overlapping area represents the amount of predictability between Therapeutic Solutions time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Therapeutic Solutions price movement. The serial correlation of -0.24 indicates that over 24.0% of current Therapeutic Solutions price fluctuation can be explain by its past prices.
Correlation Coefficient-0.24
Spearman Rank Test-0.41
Residual Average0.0
Price Variance0.0

Therapeutic Solutions lagged returns against current returns

Autocorrelation, which is Therapeutic Solutions pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Therapeutic Solutions' pink sheet expected returns. We can calculate the autocorrelation of Therapeutic Solutions returns to help us make a trade decision. For example, suppose you find that Therapeutic Solutions has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Therapeutic Solutions regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Therapeutic Solutions pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Therapeutic Solutions pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Therapeutic Solutions pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Therapeutic Solutions Lagged Returns

When evaluating Therapeutic Solutions' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Therapeutic Solutions pink sheet have on its future price. Therapeutic Solutions autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Therapeutic Solutions autocorrelation shows the relationship between Therapeutic Solutions pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Therapeutic Solutions International.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Therapeutic Pink Sheet

Therapeutic Solutions financial ratios help investors to determine whether Therapeutic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Therapeutic with respect to the benefits of owning Therapeutic Solutions security.